Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sympal is a private dental-health company developing and marketing direct-to-consumer clear aligner treatment for orthodontic correction. Its core product, SymTray, is positioned as a custom aligner system intended not only to straighten teeth but also to address bite, jawline profile, airway considerations, and jaw-joint health. The company emphasizes dentist oversight, real-time monitoring, and patented orthodontic appliance designs intended to treat broader case types than typical consumer aligner offerings. Sympal appears to operate in the orthodontic and dental device segment rather than traditional biotech or pharma, with a commercial website and active customer waitlist.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sympal.